Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.

In the past decade, there has been a profound increase in the number of studies revealing that cardenolide glycosides display inhibitory activity on the growth of human cancer cells. The use of potential cardenolide glycosides may be a worthwhile approach in anticancer research. Reevesioside A, a ca...

Full description

Bibliographic Details
Main Authors: Wohn-Jenn Leu, Hsun-Shuo Chang, She-Hung Chan, Jui-Ling Hsu, Chia-Chun Yu, Lih-Ching Hsu, Ih-Sheng Chen, Jih-Hwa Guh
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3903642?pdf=render
_version_ 1811270485540864000
author Wohn-Jenn Leu
Hsun-Shuo Chang
She-Hung Chan
Jui-Ling Hsu
Chia-Chun Yu
Lih-Ching Hsu
Ih-Sheng Chen
Jih-Hwa Guh
author_facet Wohn-Jenn Leu
Hsun-Shuo Chang
She-Hung Chan
Jui-Ling Hsu
Chia-Chun Yu
Lih-Ching Hsu
Ih-Sheng Chen
Jih-Hwa Guh
author_sort Wohn-Jenn Leu
collection DOAJ
description In the past decade, there has been a profound increase in the number of studies revealing that cardenolide glycosides display inhibitory activity on the growth of human cancer cells. The use of potential cardenolide glycosides may be a worthwhile approach in anticancer research. Reevesioside A, a cardenolide glycoside isolated from the root of Reevesia formosana, displayed potent anti-proliferative activity against human hormone-refractory prostate cancers. A good correlation (r² = 0.98) between the expression of Na⁺/K⁺-ATPase α₃ subunit and anti-proliferative activity suggested the critical role of the α₃ subunit. Reevesioside A induced G1 arrest of the cell cycle and subsequent apoptosis in a thymidine block-mediated synchronization model. The data were supported by the down-regulation of several related cell cycle regulators, including cyclin D1, cyclin E and CDC25A. Reevesioside A also caused a profound decrease of RB phosphorylation, leading to an increased association between RB and E2F1 and the subsequent suppression of E2F1 activity. The protein and mRNA levels of c-myc, which can activate expression of many downstream cell cycle regulators, were dramatically inhibited by reevesioside A. Transient transfection of c-myc inhibited the down-regulation of both cyclin D1 and cyclin E protein expression to reevesioside A action, suggesting that c-myc functioned as an upstream regulator. Flow cytometric analysis of JC-1 staining demonstrated that reevesioside A also induced the significant loss of mitochondrial membrane potential. In summary, the data suggest that reevesioside A inhibits c-myc expression and down-regulates the expression of CDC25A, cyclin D1 and cyclin E, leading to a profound decrease of RB phosphorylation. G1 arrest is, therefore, induced through E2F1 suppression. Consequently, reevesioside A causes mitochondrial damage and an ultimate apoptosis in human hormone-refractory prostate cancer cells.
first_indexed 2024-04-12T22:01:36Z
format Article
id doaj.art-48bc6de0cab044a5b752cb618d06a070
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-12T22:01:36Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-48bc6de0cab044a5b752cb618d06a0702022-12-22T03:15:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0191e8732310.1371/journal.pone.0087323Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.Wohn-Jenn LeuHsun-Shuo ChangShe-Hung ChanJui-Ling HsuChia-Chun YuLih-Ching HsuIh-Sheng ChenJih-Hwa GuhIn the past decade, there has been a profound increase in the number of studies revealing that cardenolide glycosides display inhibitory activity on the growth of human cancer cells. The use of potential cardenolide glycosides may be a worthwhile approach in anticancer research. Reevesioside A, a cardenolide glycoside isolated from the root of Reevesia formosana, displayed potent anti-proliferative activity against human hormone-refractory prostate cancers. A good correlation (r² = 0.98) between the expression of Na⁺/K⁺-ATPase α₃ subunit and anti-proliferative activity suggested the critical role of the α₃ subunit. Reevesioside A induced G1 arrest of the cell cycle and subsequent apoptosis in a thymidine block-mediated synchronization model. The data were supported by the down-regulation of several related cell cycle regulators, including cyclin D1, cyclin E and CDC25A. Reevesioside A also caused a profound decrease of RB phosphorylation, leading to an increased association between RB and E2F1 and the subsequent suppression of E2F1 activity. The protein and mRNA levels of c-myc, which can activate expression of many downstream cell cycle regulators, were dramatically inhibited by reevesioside A. Transient transfection of c-myc inhibited the down-regulation of both cyclin D1 and cyclin E protein expression to reevesioside A action, suggesting that c-myc functioned as an upstream regulator. Flow cytometric analysis of JC-1 staining demonstrated that reevesioside A also induced the significant loss of mitochondrial membrane potential. In summary, the data suggest that reevesioside A inhibits c-myc expression and down-regulates the expression of CDC25A, cyclin D1 and cyclin E, leading to a profound decrease of RB phosphorylation. G1 arrest is, therefore, induced through E2F1 suppression. Consequently, reevesioside A causes mitochondrial damage and an ultimate apoptosis in human hormone-refractory prostate cancer cells.http://europepmc.org/articles/PMC3903642?pdf=render
spellingShingle Wohn-Jenn Leu
Hsun-Shuo Chang
She-Hung Chan
Jui-Ling Hsu
Chia-Chun Yu
Lih-Ching Hsu
Ih-Sheng Chen
Jih-Hwa Guh
Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
PLoS ONE
title Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
title_full Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
title_fullStr Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
title_full_unstemmed Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
title_short Reevesioside A, a cardenolide glycoside, induces anticancer activity against human hormone-refractory prostate cancers through suppression of c-myc expression and induction of G1 arrest of the cell cycle.
title_sort reevesioside a a cardenolide glycoside induces anticancer activity against human hormone refractory prostate cancers through suppression of c myc expression and induction of g1 arrest of the cell cycle
url http://europepmc.org/articles/PMC3903642?pdf=render
work_keys_str_mv AT wohnjennleu reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT hsunshuochang reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT shehungchan reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT juilinghsu reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT chiachunyu reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT lihchinghsu reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT ihshengchen reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle
AT jihhwaguh reevesiosideaacardenolideglycosideinducesanticanceractivityagainsthumanhormonerefractoryprostatecancersthroughsuppressionofcmycexpressionandinductionofg1arrestofthecellcycle